We have demonstrated that long-term exposure of intact mice to rifampicin (6 months) induces resistance to this drug, which manifested in inability of rifampicin to suppress the growth of Mycobacterium tuberculosis in the lungs and spleen during subsequent infection. It the same time, isoniazid is still effective in these mice. In this case, the phenomenon of somatic resistance to rifampicin in mice was observed if the treatment was started in a short period (within 4 days) after infection with M. tuberculosis. If the interval between infection and rifampicin administration was longer (3 weeks), the resistance disappeared.
Similar content being viewed by others
References
Erokhina MV, Aleksandrova EA. Development of resistance to rifampicin in epithelial cells in vitro. Probl. Tuberkuleza Bol. Legkikh. 2006;83(8):58-61. Russian.
Erokhina MV, Lepekha LN, Rybalkina EYu, Nikonenko BV, Bocharova IV, Ergeshov AE. Increasing expression of multidrug resistance genes Mdr1a/b in the lung cells of mice infected with M. tuberculosis. Vestn. Tsentral. Nauvh.-Issled. Inst. Tuberkyleza. 2019;(2):16-25. https://doi.org/10.7868/S258766781902002X. Russian.
Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, Van Gestel J, Timmerman P, Zhu M, Lee E, Williams P, de Chaffoy D, Huitric E, Hoffner S, Cambau E, Truffot-Pernot C, Lounis N, Jarlier V. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science. 2005;307:223-227. https://doi.org/10.1126/science.1106753
Fletcher JI, Williams RT, Henderson MJ, Norris MD, Haber M. ABC transporters as mediators of drug resistance and contributors to cancer cell biology. Drug Resist. Updat. 2016;26:1-9. https://doi.org/10.1016/j.drup.2016.03.001
Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G. Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3). Br. J. Pharmacol. 2001;134(7):1555-1563. https://doi.org/10.1038/sj.bjp.0704390
Hamilton KO, Backstrom G, Yazdanian MA, Audus KL. P-glycoprotein efflux pump expression and activity in Calu-3 cells. J. Pharm. Sci. 2001;90(5):647-658. https://doi.org/10.1002/1520-6017(200105)90:5<647::aid-jps1021>3.0.co;2-g
Khamisipour G, Jadidi-Niaragh F, Jahromi AS, Zandi K, Hojjat-Farsangi M. Mechanisms of tumor cell resistance to the current targeted-therapy agents. Tumour Biol. 2016;37(8):10 021-10 039. https://doi.org/10.1007/s13277-016-5059-1
Nikonenko BV, Samala R, Einck L, Nacy CA. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2004;48(12):4550-4555. https://doi.org/10.1128/AAC.48.12.4550-4555.2004
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 1, pp. 69-72, January, 2021
Rights and permissions
About this article
Cite this article
Nikonenko, B.V., Bocharova, I.V. & Lepekha, L.N. Drug Resistance of Mouse Somatic Cells to Rifampicin in Experimental Tuberculosis. Bull Exp Biol Med 171, 53–55 (2021). https://doi.org/10.1007/s10517-021-05171-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-021-05171-x